ALVESCO
|
Generic Name for ALVESCO
Ciclesonide 80mcg/inh, 160mcg/inh; metered dose aerosol.
Legal Classification:
Rx
Pharmacological Class for ALVESCO
Steroid.
Manufacturer of ALVESCO
Sepracor, Inc.
|
Indications for ALVESCO
Maintenance treatment of asthma as prophylactic therapy in patients ≥12 years of age.
Adult dose for ALVESCO
Previously on bronchodilators alone: initially 80mcg twice daily, max 160mcg twice daily. Previously on inhaled corticosteroids: initially 80mcg twice daily; max 320mcg twice daily. Previously on oral corticosteroids (see literature): 320mcg twice daily. Rinse mouth after use; avoid eyes.
Children's dosing for ALVESCO
Not recommended.
Contraindications for ALVESCO
Not for primary treatment of acute attack.
Warnings/Precautions for ALVESCO
Infections. If exposed to chickenpox or measles, consider immuneglobulin prophylactic therapy. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with inhaled corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, lassitude). Monitor for hypercorticism and HPA axis suppression (if occur reduce dose gradually). Monitor for growth suppression in children. Monitor for changes in vision, increased intraocular pressure, cataracts. Pregnancy (Cat.C). Nursing mothers.
Adverse Reactions for ALVESCO
Headache, nasopharyngitis, sinusitis, throat pain, upper respiratory infection, arthralgia, nasal congestion, back pain; rare: bronchospasm, immunosuppression, glaucoma, cataracts, oral candidiasis, decreased bone mineral density.
How is ALVESCO supplied?
Inhaler—6.1g (60 inh)
Related Disease:
Asthma~antiasthmatics